Leap Therapeutics, Inc.
LPTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$68 | -$81 | -$55 | -$41 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $6 | $5 | $5 | $3 |
| Change in WC | $1 | $3 | -$1 | $1 |
| Other Non-Cash | $0 | $30 | $1 | $1 |
| Operating Cash Flow | -$60 | -$44 | -$49 | -$35 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $50 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$1 | $0 | $0 |
| Investing Cash Flow | $0 | $49 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $40 | $0 | $0 | $97 |
| Stock Repurch. | $0 | -$0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$3 | -$0 | -$0 | $1 |
| Financing Cash Flow | $37 | -$0 | -$0 | $98 |
| Forex Effect | -$0 | -$0 | -$0 | -$0 |
| Net Chg. in Cash | -$23 | $5 | -$49 | $63 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $71 | $66 | $115 | $52 |
| End Cash | $47 | $71 | $66 | $115 |
| Free Cash Flow | -$60 | -$44 | -$49 | -$35 |